Deferred Tax Assets, Valuation Allowance in USD of XBiotech Inc. from Q4 2013 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
XBiotech Inc. quarterly Deferred Tax Assets, Valuation Allowance history and change rate from Q4 2013 to Q4 2024.
  • XBiotech Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $26,382,000, a 50% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

XBiotech Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $26,382,000 +$8,806,000 +50% 31 Dec 2024 10-K 18 Mar 2025 2024 FY
Q4 2023 $17,576,000 +$6,351,000 +57% 31 Dec 2023 10-K 18 Mar 2025 2024 FY
Q4 2022 $11,225,000 +$4,751,000 +73% 31 Dec 2022 10-K 15 Mar 2024 2023 FY
Q4 2021 $6,474,000 -$1,111,000 -15% 31 Dec 2021 10-K 15 Mar 2023 2022 FY
Q4 2020 $7,585,000 +$4,791,000 +171% 31 Dec 2020 10-K 15 Mar 2022 2021 FY
Q4 2019 $2,794,000 -$45,648,000 -94% 31 Dec 2019 10-K 16 Mar 2021 2020 FY
Q4 2018 $48,442,000 +$2,662,000 +5.8% 31 Dec 2018 10-K 16 Mar 2021 2020 FY
Q4 2017 $45,780,000 +$5,297,000 +13% 31 Dec 2017 10-K 16 Mar 2020 2019 FY
Q4 2016 $40,483,000 +$11,516,000 +40% 31 Dec 2016 10-K/A 15 Mar 2019 2018 FY
Q4 2015 $28,967,000 +$10,319,000 +55% 31 Dec 2015 10-K 16 Mar 2018 2017 FY
Q4 2014 $18,648,000 -$10,319,000 -36% 31 Dec 2014 10-K 16 Mar 2017 2016 FY
Q4 2013 $28,967,000 31 Dec 2013 10-K 15 Apr 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.